INCREASED THYROID-STIMULATING HORMONE LEVEL AS A MARKER OF PROGRESSION OF HEART FAILURE IN CARDIAC PATIENTS
- Authors: Adamchik A.S1, Panchenko D.I1
-
Affiliations:
- Issue: No 5 (2016)
- Pages: 86-88
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/288774
- ID: 288774
Cite item
Open Access
Access granted
Abstract
The study including 42 patients has investigated the relationship of subclinical hypothyroidism (SH) with the development and progression of heart failure in patients with coronary heart disease and hypertension. It was found that SH (increased thyroid-stimulating hormone level) is accompanied by maladaptive restructuring of the left ventricle and its dilation, which is a prerequisite for an earlier development and progression of chronic heart failure in cardiac patients. These data suggest the presence of the negative impact of the SH on the dilation of the left atrium and development of atrial fibrillation, which requires a large-scale studies on the subject. They also put on the agenda the question of whether screening for thyroid disorders in cardiac patients and earlier initiation of hormone replacement therapy for the SH will reduce the risk and progression of heart failure.
Full Text
About the authors
A. S Adamchik
SBEI HPE “Kuban State Medical University" of RMPH MD, Prof., Head of the Department of Propaedeutics of Internal Diseases Krasnodar
D. I Panchenko
SBEI HPE “Kuban State Medical University" of RMPH Krasnodar
References
- Фадеев В.В. Проблемы заместительной терапии гипотиреоза: современность и перспективы. Клиническая и экспериментальная тиреоидология. 2012;8(3).
- Hollowell J.G., Staehling N.W., Flanders W.D., Hannon W.H., Gunter E.W., Spencer C.A., Braverman L.E. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 2002; 87:489-99.
- Völzke H., Schmidt C.O., John U., Wallaschofski H., Dörr M., Nauck M. Reference levels for serum thyroid function tests of diagnostic and prognostic significance. Horm. Metab. Res. 2010;42:809-14.
- Völzke H., Alte D., Kohlmann T., Lüdemann J., Nauck M., John U., Meng W. Reference intervals of serum thyroid function tests in a previously iodine-deficient area. Thyroid. 2005;15(3):279-85.
- Фадеев В.В., Мельниченко Г.А. Гипотиреоз. Руководство для врачей. М., 2002. C. 147-70.
- Сыч Ю.П., Калашникова В.Ю., Сыркин А.Л. и др. Нарушения функционального состояния сердечно-сосудистой системы при субклиническом гипотиреозе. Клин. мед. 2003;11:4-9.
- Biondi B., Palmieri E.A., Lombardi G., Fazio S. Subclinical hypothyroidism and cardiac function. Thyroid. 2002;12:505-10.
- Hamano K., Inoue M. Increased risk for atherosclerosis estimated by pulse wave velocity in hypothyroidism and its reversal with appropriate thyroxine treatment. Endocr. J. 2005;52(1):95-101.
- Rodondi N., Bauer D., Cappola A., Cornuz J., Robbins J., Fried L.P., Ladenson P.W., Vittinghoff E., Gottdiener J.S., Newman A.B. Subclinical thyroid dysfunction, cardiac function and the risk of heart failure: the cardiovascular health study. J. Am. Coll. Cardiol. 2008;52: 1152-59.
Supplementary files
